Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent (Q34075190)

30 July 2017

1 reference

title

Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent (English)

1 reference

30 July 2017

Davidson MH

1

1 reference

30 July 2017

Dicklin MR

series ordinal

2

1 reference

30 July 2017

Maki KC

series ordinal

3

1 reference

30 July 2017

Kleinpell RM

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

11

1 reference

30 July 2017

page(s)

2663-2671

1 reference

Cholesterol reduction: weighing the benefits and risks

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Choosing the right lipid-regulating agent. A guide to selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2663

10.1517/13543784.9.11.2663

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference